Along with weight loss, exercise, and nutrition, employers now target sleep improvements in employees; a Republican member of the FTC supports Medicare drug price negotiations; sepsis is likely responsible for 20% of deaths worldwide.
Employers are focusing on improvements in workers’ sleep as a way to reduce company medical costs and improve employee health, according to Kaiser Health News. This new area of focus comes after wellness issues like weight loss, exercise, and nutrition were targeted by employers in the past. One company included in the article, Southern Co, has screened around 4000 of its 30,000 employees for sleep apnea in the past 3 years and saw a $1.2-million reduction in medical costs in 2018. One in 4 large employers offer programs to assist workers in improving sleep, the article reports, but the long-term effects remain unknown.
Christine Wilson, the Republican commissioner of the Federal Trade Commission (FTC) appointed by President Trump, expressed her support for Medicare negotiations on drug prices, The Hill reports. Speaking at a health care conference in Washington, DC, Wilson broke ranks from her Republican colleagues, who have historically opposed the notion. “I think part of the problem is that the federal government has not been able to negotiate under certain parts of Medicare and Medicaid for pharmaceutical prices,” Wilson said. Democrats passed a bill in the House in December addressing the issue, but the President and Senate Republicans rejected it.
A recent study published in Lancet lists sepsis, sometimes called blood poisoning, as a major contributor to deaths around the world. The disease arises when a body overreacts to an infection, which can lead to multiple-organ failure, NPR reports. About 270,000 deaths occur as a result of the disease in the United States each year, but the global death rate has dropped by about half since 1990. The study analyzed more than 100 million death certificates between 1990 and 2007 and concluded that sepsis is twice as common as previously thought. In 2017, researchers determined 11 million people worldwide died from the disease out of 56 million deaths.
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV
April 21st 2025Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Comparing Breast Cancer Treatment Outcomes Between Fee-for-Service and Medicare Advantage
April 4th 2025This study examined postdiagnosis breast cancer treatment outcomes for Medicare Advantage vs fee-for-service (FFS) Medicare in Ohio and found no significant differences overall but disparities for Black patients with FFS Medicare.
Read More